CHINA PHARMA HOLDINGS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
China Pharma Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • China Pharma Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.09M, a 52.1% decline year-over-year.
  • China Pharma Holdings, Inc. annual Operating Income (Loss) for 2023 was -$2.75M, a 22.5% increase from 2022.
  • China Pharma Holdings, Inc. annual Operating Income (Loss) for 2022 was -$3.55M, a 24.1% decline from 2021.
  • China Pharma Holdings, Inc. annual Operating Income (Loss) for 2021 was -$2.86M, a 10.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.09M -$372K -52.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$1.39M -$935K -205% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q4 2023 -$2.75M -$1.18M -$15.5K -1.32% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$2.74M -$714K -$24.9K -3.61% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$2.71M -$456K +$323K +41.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$3.03M -$397K +$514K +56.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$3.55M -$1.17M -$520K -80.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$3.03M -$689K +$73.8K +9.67% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$3.1M -$780K -$26.6K -3.54% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$3.08M -$912K -$215K -30.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$2.86M -$649K +$453K +41.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$3.31M -$762K +$190K +20% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.5M -$753K -$828K -1104% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.68M -$696K -$97.2K -16.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$2.58M -$1.1M +$17.6M +94.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$20.2M -$952K -$307K -47.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$19.8M $75K +$828K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$20.7M -$599K -$265K -79.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$20.4M -$18.7M -$11.2M -149% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$9.24M -$645K +$1.29M +66.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$10.5M -$753K +$111K +12.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$10.6M -$334K -$194K -138% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$10.4M -$7.51M +$6.18M +45.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$16.6M -$1.93M +$124K +6.03% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$16.8M -$864K +$1.27M +59.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$18M -$141K +$662K +82.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$18.7M -$13.7M -$10.6M -347% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 -$8.05M -$2.06M -$508K -32.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$7.55M -$2.13M +$90.2K +4.06% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$7.64M -$803K +$519K +39.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$8.16M -$3.06M +$12.1M +79.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$20.3M -$1.55M -$4.74M -148% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$15.5M -$2.22M -$3.66M -254% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$11.9M -$1.32M +$2.44M +64.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$14.3M -$15.2M +$6.73M +30.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$21M $3.19M +$9.19M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$30.2M $1.44M +$9.97M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$40.2M -$3.76M -$1.43M -61.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$38.8M -$21.9M -$13.7M -168% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$25M -$5.99M -$3.3M -123% Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-28
Q2 2014 -$21.7M -$8.53M -$3.77M -79.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$17.9M -$2.34M +$664K +22.1% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-12-28
Q4 2013 -$18.6M -$8.16M -$6.82M -510% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-12-28
Q3 2013 -$11.8M -$2.69M -$4.31M -266% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$7.48M -$4.76M -$6.97M -315% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$509K -$3M -$6.41M -188% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $5.91M -$1.34M -$6.3M -127% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 $12.2M $1.62M -$4.35M -72.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $16.6M $2.21M -$3.55M -61.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $20.1M $3.41M -$1.92M -36.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 $22M $4.96M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 $5.96M -$232K -3.74% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $5.76M -$196K -3.29% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $5.34M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 $6.2M Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-03-06
Q2 2010 $5.96M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.